Last Updated: April 21, 2026 | Focus: matching CRISPR library size and risk tolerance to the right synthesis vendor

Choose a Synthesis Platform for CRISPR sgRNA Libraries

Advanced25-45 minutes

Use this page when your guide set is already defined and you need to decide which vendor path best fits the library size, oligo length, turnaround target, representation risk, and final order format. The goal is not just to pick the cheapest platform. It is to pick the one that still leaves you with a usable screen after synthesis and pre-screen QC.

Need the adjacent execution page?

Use the CRISPR library design workflow if you still need to clean the guide set, run pre-order QC, or estimate coverage. Stay on this page if the main decision is which vendor path fits the final library.

Open CRISPR library workflowOpen Vendor Format Adapter

What are you trying to decide?

Which metrics matter before I compare vendor quotesHow Twist, IDT, GenScript, and Dynegene differ in practiceWhich platform fits my library size and risk toleranceWhat must be checked before final vendor submission

Quick Takeaways

  • •Uniformity and dropout risk often matter more than the lowest quote once the screen becomes large.
  • •Focused libraries can justify a faster or cheaper platform if the post-synthesis QC plan is still strong.
  • •Vendor comparison is incomplete until you normalize file requirements, delivery format, and turnaround assumptions.
  • •Post-synthesis NGS QC should be treated as mandatory, not optional, across every vendor path.

Table of Contents

Vendor decision inputsVendor comparisonPlatform profilesDecision frameworkPre-order checklistFAQsRelated pages

1. Which Inputs Matter Before You Compare CRISPR Library Vendors?

Vendor comparison only becomes useful after you normalize the inputs. A quote for a short focused library is not directly comparable to a quote for a long genome-wide construct, even if both are described as CRISPR libraries.

Decision inputWhy it mattersWhat to record before asking for quotes
Guide countPool scale changes the vendor sweet spot immediatelyFocused, medium, or genome-wide library size
Full oligo lengthLonger constructs change synthesis risk and platform eligibilitySpacer plus all flanking handles and cloning sequence
Representation toleranceSome screens can absorb more bias than othersAcceptable dropout and how much sequencing depth you can spend to compensate
Turnaround requirementFast iteration can outweigh perfect specs in pilot projectsHard timeline vs preferred timeline
File-format constraintsSubmission friction can delay the order even after technical approvalRequired CSV layout, naming scheme, and special characters to avoid

2. How Do the Major CRISPR Library Vendors Compare?

VendorTypical fitMax lengthRelative error profileWhat to watch
Twist BioscienceLarge and genome-wide screensUp to 300 ntLowest relative error and strongest uniformity in this comparisonUsually the premium path; verify lead time and file prep early
IDT oPoolsFocused and medium-size librariesUp to 350 ntStrong quality with fast turnaround for smaller poolsCan become less attractive as the library gets large
GenScriptBudget-conscious high-capacity ordersUp to 200 ntHigher relative error than the premium optionsTreat post-synthesis NGS QC as mandatory
DynegeneBulk production and cost-sensitive procurementUp to 200 ntSimilar relative risk profile to other budget array optionsVerify current formatting rules and QC expectations directly

3. When Does Each Platform Path Make the Most Sense?

Twist Bioscience

Best fit when library representation is the first priority and the screen is too expensive to tolerate avoidable dropout.

  • •Strong option for genome-wide and other very large screens
  • •Good fit when longer constructs and tighter representation matter
  • •Usually not the lowest-cost procurement path

IDT oPools

Best fit when you need a focused or medium-size library with good quality and a faster iteration cycle.

  • •Often attractive for targeted or pilot libraries
  • •Strong balance of speed and quality on smaller pools
  • •Less compelling when the guide count becomes very large

GenScript

Useful when budget pressure or bulk capacity matters more than chasing the best-in-class representation profile.

  • •Common budget-conscious option for larger orders
  • •Requires a more disciplined downstream QC plan
  • •Quote comparison should include the cost of extra validation

Dynegene

Useful for cost-sensitive bulk orders when the team can absorb more hands-on validation after delivery.

  • •Can be competitive on large production volume
  • •Confirm current file rules and bulk logistics before committing
  • •Treat pre-order and post-order QC as non-negotiable

4. Which Platform Fits Your Library Size and Risk Tolerance?

1

Genome-wide or otherwise hard-to-repeat screens

Bias toward the platform with the strongest representation quality, even if the quote is higher. The downstream cost of a weak library usually dominates the upfront savings.

2

Focused screens and pilot libraries

Balance turnaround, quality, and cost. Faster iteration can matter more here, especially when the library can be regenerated or refined without months of downstream work.

3

Budget-constrained programs

Include the real cost of extra QC, deeper sequencing, and possible redesign when comparing the lower-cost options. The cheapest order is not always the cheapest usable library.

4

Any vendor path

Do not skip post-synthesis representation checks. Pre-order comparison helps you avoid obvious mistakes, but only NGS QC on the delivered pool tells you whether the screen can start safely.

5. What Should You Verify Before Vendor Submission?

  1. Check the guide set for GC extremes and obvious synthesis-unfriendly sequences in the Batch Sequence QC.
  2. Screen secondary structure risk in the sequences that still look marginal using the Secondary Structure Predictor.
  3. Estimate how much representation loss your screen can absorb and size the experiment with the Coverage Calculator.
  4. Review pool-uniformity implications before ordering with the Uniformity Estimator.
  5. Convert the final file to the vendor-ready CSV layout in the Vendor Format Adapter.

Frequently Asked Questions About CRISPR Library Vendor Choice

Which platform is usually best for genome-wide CRISPR libraries?▾
For very large libraries, the best fit usually comes from the platform that gives you the strongest representation uniformity and the lowest dropout risk rather than the cheapest quote. That is why large screens often favor the highest-uniformity vendor even when the per-oligo price is higher.
When does turnaround matter more than the absolute best error rate?▾
Turnaround starts to dominate when you are running a focused library, pilot screen, or fast iteration cycle and can tolerate a tighter post-synthesis QC loop. In that case, the fastest acceptable platform can be the right choice even if it is not the best-in-class option for the largest genome-wide screens.
Should I still plan post-synthesis NGS QC if the vendor promises high quality?▾
Yes. Vendor quality claims do not replace representation checks on your actual received pool. Post-synthesis NGS QC is still the fastest way to verify dropout, guide balance, and whether the library is good enough to move into screening.
What should I prepare before asking vendors for quotes?▾
Prepare the final guide count, full oligo length, any required flanking sequences, the desired delivery amount, preferred turnaround, acceptable dropout risk, and the file format requirements. Without those inputs, quote comparisons usually become vague and hard to normalize across vendors.

Start the vendor-selection handoff with clean library inputs

If the guide set is not fully cleaned yet, start in the CRISPR library workflow. If the sequences are ready and you just need the final vendor-ready file, jump to the Vendor Format Adapter.

Open CRISPR Library WorkflowOpen Vendor Format Adapter